Codasip University Program spurs innovation and boosts curriculums
Keith Graham appointed Head of University Program Munich, 10 March 2022 – Codasip, the leader…
News
Bluejay Diagnostics, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
Testing program underway for lead product candidate, the Symphony IL-6 Test, in support of an…
Amicus Therapeutics Announces Presentation and Posters at the 2022 MDA Clinical & Scientific Conference
PHILADELPHIA, March 10, 2022 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD), today announced one oral…
Foghorn Therapeutics Provides Full Year 2021 Corporate Update and 2022 Outlook
– Initial clinical data for FHD-286 expected in H1’22 and FHD-609 as early as H1’22…
ProMIS Neurosciences to Present at the 2022 International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PDTM) and Related Neurological Disorders
Optimizing vaccine design for Alzheimer’s disease TORONTO, Ontario and CAMBRIDGE, Mass., March 10, 2022 (GLOBE…
Autolus Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Progress
– Conference call to be held on March 10, 2022 at 8:30 am ET/1:30 pm…
Oncorus to Present at the Oppenheimer 32nd Annual Healthcare Conference
CAMBRIDGE, Mass., March 10, 2022 (GLOBE NEWSWIRE) — Oncorus, Inc. (Nasdaq: ONCR), a viral immunotherapies…
Galera Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Corporate Updates
Positive Phase 3 ROMAN trial of avasopasem for severe oral mucositis met primary and secondary…
Bioventus Reports Fourth Quarter and Full Year 2021 Financial Results; Introduces Full Year 2022 Financial Guidance
DURHAM, N.C., March 10, 2022 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or “the…
Tiziana Announces Positive Clinical Data from A Secondary Progressive Multiple Sclerosis Patient Treated for Six Months with Intranasally Administered Foralumab, A Fully Human Anti-CD3 Monoclonal Antibody
Intranasal foralumab was well-tolerated with no adverse reactions or laboratory abnormalities after 6 months of…
Genocea Provides Fourth Quarter 2021 Corporate Update
Initial GEN-011 clinical trial data to be presented at AACR Conference call today at 8:30…
Akouos Appoints Aaron Tward, M.D., Ph.D., as Chief Scientific Officer
BOSTON, March 10, 2022 (GLOBE NEWSWIRE) — Akouos, Inc. (NASDAQ: AKUS), a precision genetic medicine…
The Middle East Blockchain Ecosystem “Crypto Oasis” is Expected to Reach 1000+ Organisations Target by Q2 2022
Innovation and disruption ignites surge within the Blockchain industry, and the local regulators are supporting…
DeFi Captive Insurance Provider SuretyBlock, a Subsidiary of Ocean Falls Blockchain, Signs Fronting Agreement with Fortress Insurance
Vancouver, British Columbia–(Newsfile Corp. – March 10, 2022) – Ocean Falls Blockchain Corp. (“OFB” or…
Chronus Announces Appointments to New C-Level Leadership Positions
New CRO and CFO roles will strengthen operational evolution, support company growth BELLEVUE, Wash.–(BUSINESS WIRE)–#Chronus—Chronus,…
Baidu Global’s AI-Integrated Marketing Platform MediaGo to Include New Offerings Powered by Xandr
Collaboration strengthens capabilities for advertisers using MediaGo SAN FRANCISCO & SINGAPORE–(BUSINESS WIRE)–Baidu Global today announced…
Sierra Oncology Reports 2021 Year End Results
– Planned Q2 2022 NDA submission following positive topline data from MOMENTUM clinical trial of…
Xeris Biopharma Reports Fourth Quarter and Full-year 2021 Financial Results and Recent Events
Acquisition and integration of Strongbridge Biopharma completed; $50M in synergies to be realized by year-end…
First American Financial Corporation Appoints Paul Hurst Chief Innovation Officer
—Venture and tech executive takes on new position focused on enhancing First American’s leadership in…
Veritone Showcases Multilingual Synthetic Voices of Executive Leadership on Veritone’s Fourth Quarter and Full Year 2021 Financial Results Call
With the iconic voice of Vin Scully opening Veritone’s quarterly earnings call, Veritone’s CEO, President,…